Varex Imaging (NASDAQ:VREX) Issues Q1 2026 Earnings Guidance

Varex Imaging (NASDAQ:VREX) updated its first quarter 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.050-0.250 for the period, compared to the consensus estimate of 0.170. The company issued revenue guidance of $200.0 million-$215.0 million, compared to the consensus revenue estimate of $206.5 million.

Varex Imaging Trading Up 3.8%

VREX opened at $11.86 on Wednesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 3.51 and a quick ratio of 1.82. Varex Imaging has a fifty-two week low of $6.76 and a fifty-two week high of $16.93. The company’s 50 day moving average price is $11.83 and its two-hundred day moving average price is $9.84. The firm has a market capitalization of $492.19 million, a price-to-earnings ratio of -3.69 and a beta of 0.98.

Varex Imaging (NASDAQ:VREX) last issued its quarterly earnings results on Tuesday, November 18th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.19. The company had revenue of $228.90 million for the quarter, compared to analyst estimates of $219.26 million. Varex Imaging had a negative net margin of 16.13% and a positive return on equity of 5.54%. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. As a group, research analysts predict that Varex Imaging will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Varex Imaging in a research report on Wednesday, October 8th. B. Riley reaffirmed a “buy” rating and issued a $16.00 price objective (up from $12.00) on shares of Varex Imaging in a research note on Friday, August 8th. Finally, Wall Street Zen downgraded shares of Varex Imaging from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 9th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, Varex Imaging currently has an average rating of “Hold” and a consensus price target of $19.50.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Quarry LP purchased a new stake in shares of Varex Imaging during the 3rd quarter worth approximately $64,000. Aquatic Capital Management LLC purchased a new stake in Varex Imaging in the third quarter worth $117,000. Inceptionr LLC bought a new stake in shares of Varex Imaging in the third quarter valued at $152,000. Glenmede Investment Management LP purchased a new position in shares of Varex Imaging during the 3rd quarter valued at $153,000. Finally, BNP Paribas Financial Markets increased its holdings in Varex Imaging by 18.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock worth $113,000 after acquiring an additional 2,036 shares during the last quarter.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.